BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19674539)

  • 1. Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies.
    Vanhee M; Delputte PL; Delrue I; Geldhof MF; Nauwynck HJ
    Vet Res; 2009; 40(6):63. PubMed ID: 19674539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
    Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
    Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
    Nilubol D; Platt KB; Halbur PG; Torremorell M; Harris DL
    Vet Microbiol; 2004 Aug; 102(1-2):11-8. PubMed ID: 15288922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
    Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
    BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions.
    Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL
    J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine.
    Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine.
    Cao J; Wang X; Du Y; Li Y; Wang X; Jiang P
    Vaccine; 2010 Nov; 28(47):7514-22. PubMed ID: 20851084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs.
    Li J; Jiang P; Li Y; Wang X; Cao J; Wang X; Zeshan B
    Vaccine; 2009 Feb; 27(6):825-32. PubMed ID: 19070639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanideā„¢ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets.
    Tabynov K; Sansyzbay A; Tulemissova Z; Tabynov K; Dhakal S; Samoltyrova A; Renukaradhya GJ; Mambetaliyev M
    Vet Microbiol; 2016 Aug; 192():81-89. PubMed ID: 27527768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows.
    Papatsiros VG; Alexopoulos C; Kritas SK; Koptopoulos G; Nauwynck HJ; Pensaert MB; Kyriakis SC
    J Vet Med B Infect Dis Vet Public Health; 2006 Aug; 53(6):266-72. PubMed ID: 16907957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
    Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the functionality of viral entry-associated domains of porcine reproductive and respiratory syndrome virus during inactivation procedures, a potential tool to optimize inactivated vaccines.
    Delrue I; Delputte PL; Nauwynck HJ
    Vet Res; 2009; 40(6):62. PubMed ID: 19674538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena.
    Trus I; Bonckaert C; van der Meulen K; Nauwynck HJ
    Vaccine; 2014 May; 32(25):2995-3003. PubMed ID: 24709589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant.
    Chia MY; Hsiao SH; Chan HT; Do YY; Huang PL; Chang HW; Tsai YC; Lin CM; Pang VF; Jeng CR
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):234-42. PubMed ID: 20053461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18.
    Shen G; Jin N; Ma M; Jin K; Zheng M; Zhuang T; Lu H; Zhu G; Jin H; Jin M; Huo X; Qin X; Yin R; Li C; Li H; Li Y; Han Z; Chen Y; Jin M
    Vaccine; 2007 May; 25(21):4193-202. PubMed ID: 17418456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.